GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kainos Medicine Inc (XKRX:284620) » Definitions » EBITDA Margin %

Kainos Medicine (XKRX:284620) EBITDA Margin % : -1,597.84% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Kainos Medicine EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Kainos Medicine's EBITDA for the three months ended in Mar. 2024 was ₩-2,216.7 Mil. Kainos Medicine's Revenue for the three months ended in Mar. 2024 was ₩138.7 Mil. Therefore, Kainos Medicine's EBITDA margin for the quarter that ended in Mar. 2024 was -1,597.84%.


Kainos Medicine EBITDA Margin % Historical Data

The historical data trend for Kainos Medicine's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kainos Medicine EBITDA Margin % Chart

Kainos Medicine Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial - - -826.41 -10,229.03 -5,134.84

Kainos Medicine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,340.32 -10,246.81 -8,301.87 -2,639.44 -1,597.84

Competitive Comparison of Kainos Medicine's EBITDA Margin %

For the Biotechnology subindustry, Kainos Medicine's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kainos Medicine's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kainos Medicine's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Kainos Medicine's EBITDA Margin % falls into.



Kainos Medicine EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Kainos Medicine's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-13726.045/267.312
=-5,134.84 %

Kainos Medicine's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-2216.689/138.73
=-1,597.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kainos Medicine  (XKRX:284620) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Kainos Medicine EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Kainos Medicine's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kainos Medicine (XKRX:284620) Business Description

Traded in Other Exchanges
N/A
Address
16, Daewangpangyo-ro 712 beon-gil, 4th Floor, Institut Pasteur Korea, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13488
Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.

Kainos Medicine (XKRX:284620) Headlines

No Headlines